High-Resolution Deletion Mapping of 15q13.2-q21.1 in Transitional Cell Carcinoma of the Bladder

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7657-7662

  Natrajan, Rachael ^a   Louhelainen, Jari ^a   Williams, Sarah ^a   Laye, Jonathan ^a   Knowles, Margaret A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RAD51 PROTEIN;

ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CHROMOSOME 15Q; CONTROLLED STUDY; DISEASE MARKER; DNA REPAIR; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE INACTIVATION; GENE LOSS; GENE MAPPING; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOTIC RECOMBINATION; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 15; DISEASE PROGRESSION; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; RAD51 RECOMBINASE; URINARY BLADDER NEOPLASMS;

EID: 0345707580     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Knowles, M. A. The genetics of transitional cell carcinoma: progress and potential clinical application. Br. J. Urol. Int., 84: 412-427, 1999.
2. Knowles, M. A. What we could do now: molecular pathology of bladder cancer. Mol. Pathol., 54: 215-221, 2001.
3. Caims, P., Shaw, M. E., and Knowles, M. A. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene, 8: 1083-1085, 1993.
4. Billerey, C., Chopin, D., Aubriot-Lorton, M. H., Ricol, D., Gil Diez de Medina, S., Van Rhijn, B., Bralet, M. P., Lefrere-Belda, M. A., Lahaye, J. B., Abbou, C. C., Bonaventure, J., Zafrani, E. S., van der Kwast, T., Thiery, J. P., and Radvanyi, F. Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am. J. Pathol., 158: 1955-1959, 2001.
5. Knowles, M. A., Elder, P. A., Williamson, M., Cairns, J. P., Shaw, M. E., and Law, M. G. Allelotype of human bladder cancer. Cancer Res., 54: 531-538, 1994.
6. Wheeless, L. L., Reeder, J. E., Han, R., O'Connell, M. J., Frank, I. N., Cockett, A. T., and Hopman, A. H. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei. Cytometry, 17: 319-326, 1994.
7. Richter, J., Jiang, F., Gorog, J. P., Sartorius, G., Egenter, C., Gasser, T. C., Moch, H., Mihatsch, M. J., and Sauter, G. Marked genetic differences between stage pTa and stage pTl papillary bladder cancer detected by comparative genomic hybridization. Cancer Res., 57: 2860-2864, 1997.
8. Zhao, J., Richter, J., Wagner, U., Roth, B., Schraml, P., Zellweger, T., Ackermann, D., Schmid, U., Moch, H., Mihatsch, M. J., Gasser, T. C., and Sauter, G. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res., 59: 4658-4661, 1999.
9. Kallioniemi, A., Kallioniemi, O-P., Citro, G., Sauter, G., DeVries, S., Kerschmann, R., Caroll, P., and Waldman, F. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridisation. Genes Chromosomes Cancer. 12: 213-219, 1995.
10. Girard, L., Zochbauer-Muller, S., Virmani, A. K., Gazdar, A. F., and Minna, J. D. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res., 60: 4894-4906, 2000.
11. Wick, W., Petersen, I., Schmutzler, R. K., Wolfarth, B., Lenartz, D., Bierhoff, E., Hummerich, J., Muller, D. J., Stangl, A. P., Schramm, J., Wiestler, O. D., and von Deimling, A. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene, 12: 973-978, 1996.
12. Gonzalez, R., Silva, J. M., Dominguez, G., Garcia, J. M., Martinez, G., Vargas, J., Provencio, M., Espana, P., and Bonilla, F. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br. J. Cancer, 81: 503-509, 1999.
13. Balsara, B. R., Bell, D. W., Sonoda, G., De Rienzo, A., du Manoir, S., Jhanwar, S. C., and Testa, J. R. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. Cancer Res., 59: 450-454, 1999.
14. De Rienzo, A., Balsara, B. R., Apostolou, S., Jhanwar, S. C., and Testa, J. R. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma. Oncogene, 20: 6245-6249, 2001.
15. Park, W. S., Park, J. Y., Oh, R. R., Yoo, N. J., Lee, S. H., Shin, M. S., Lee, H. K., Han, S., Yoon, S. K., Kim, S. Y., Choi, C., Kim, P. J., Oh, S. T., and Lee, J. Y. A distinct tumor suppressor gene locus on chromosome 15q21.1 in sporadic form of colorectal cancer. Cancer Res., 60: 70-73, 2000.
16. Jonson, T., Gorunova, L., Dawiskiba, S., Andren-Sandberg, A., Stenman, G., ten Dijke, P., Johansson, B., and Hoglund, M. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer. Genes Chromosomes Cancer, 24: 62-71, 1999.
17. Paez, G., Richard, S., Bianchi, M. S., and Bianchi, N. O. Loss of heterozygosity (LOH) in 15q26.2→ter in breast cancer. Mutat. Res., 484: 103-106, 2001.
18. Tomlinson, I., Rahman, N., Frayling, I., Mangion, J., Barfoot, R., Hamoudi, R., Seal, S., Northover, J., Thomas, H. J., Neale, K., Hodgson, S., Talbot, I., Houlston, R., and Stratton, M. R. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology, 116: 789-795, 1999.
19. Boukamp, P., Peter, W., Pascheberg, U., Altmeier, S., Fasching, C., Stanbridge, E. J., and Fusenig, N. E. Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss. Oncogene, 11: 961-969, 1995.
20. Carling, T., Imanishi, Y., Gaz, R. D., and Arnold, A. RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutations. Clin. Endocrinol. (Oxf.). 51: 403-407, 1999.
21. Schmutte, C., Tombline, G., Rhiem, K., Sadoff, M. M., Schmutzler, R., von Deimling, A., and Fishel, R. Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH). Cancer Res., 59: 4564-4569, 1999.
22. Yeager, T. R., DeVries, S., Jarrard, D. F., Kao, C., Nakada, S. Y., Moon, T. D., Bruskewitz, R., Stadler, W. M., Meisner, L. F., Gilchrist, K. W., Newton, M. A., Waldman, F. M., and Reznikoff, C. A. Overcoming cellular senescence in human cancer pathogenesis. Genes Dev., 12: 163-174, 1998.
23. Rigaud, G., Moore, P. S., Zamboni, G., Orlandini, S., Taruscio, D., Paradisi, S., Lemoine, N. R., Kloppel, G., and Scarpa, A. Allelotype of pancreatic acinar cell carcinoma. Int. J. Cancer, 88: 772-777, 2000.
24. Beatty, J., Terry, A., MacDonald, J., Gault, E., Cevario, S., O'Brien, S. J., Cameron, E., and Neil, J. C. Feline immunodeficiency virus integration in B-cell lymphoma identifies a candidate tumor suppressor gene on human chromosome 15q15. Cancer Res., 62: 7175-7180, 2002.
25. Carling, T., Imanishi, Y., Gaz, R. D., and Arnold, A. RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutations. Clin. Endocrinol. (Oxf.). 51: 403-407, 1999.
26. Sonoda, E., Sasaki, M. S., Buerstedde, J. M., Bezzubova, O., Shinohara, A., Ogawa, H., Takata, M., Yamaguchi-Iwak, Y., and Takeda, S. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J., 17: 598-608, 1998.
27. Lim, D. S., and Hasty, P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol., 16: 7133-7143, 1996.
28. Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y., and Morita, T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA. 93: 6236-6240, 1996.
29. Raderschall, E., Stout, K., Freier, S., Suckow, V., Schweiger, S., and Haaf, T. Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res., 62: 219-225, 2002.
30. Sbrana, I., Zavattari, P., Barale, R., and Musio, A. Common fragile sites on human chromosomes represent transcriptionally active regions: evidence from camptothecin. Hum. Genet., 102: 409-414, 1998.
31. Gonzalez-Zulueta, M., Ruppert, J. M., Tokino, K., Tsai, Y. C., Spruck, C. H., III, Miyao, N., Nichols, P. W., Hermann, G. G., Horn, T., Steven, K., Summerhayes, I., Sidransky, D., and Jones, P. Microsatellite instability in bladder cancer. Cancer Res., 53: 5620-5623, 1993.
32. Bonnal, C., Ravery, V., Toublanc, M., Bertrand, G., Boccon-Gibod, L., Henin, D., and Grandchamp, B. Absence of microsatellite instability in transitional cell carcinoma of the bladder. Urology, 55: 287-291, 2000.
33. Danaee, H., Nelson, H. H., Karagas, M. R., Schned, A. R., Ashok, T. D., Hirao, T., Perry, A. E., and Kelsey, K. T. Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene, 21: 4894-4899, 2002.
34. Dodson, M. K., Hartmann, L. C., Cliby, W. A., DeLacey, K. A., Keeney, G. L., Ritland, S. R., Su, J. Q., Podratz, K. C., and Jenkins, R. B. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res., 53: 4456-4460, 1993.
35. Serra, E., Rosenbaum, T., Nadal, M., Winner. U., Ars, E., Estivill, X., and Lazaro, C. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Nat. Genet., 28: 294-296, 2001.
36. Thiagalingam, S., Laken. S., Willson, J. K., Markowitz, S. D., Kinzler, K. W., Vogelstein, B., and Lengauer, C. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc. Natl. Acad. Sci. USA, 98: 2698-2702, 2001.
37. Mahlamaki, E. H., Hoglund, M., Gorunova, L., Karhu, R., Dawiskiba, S., Andren-Sandberg, A., Kallioniemi, O. P., and Johansson, B. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer, 20: 383-391, 1997.
38. Beder, L. B., Gunduz, M., Ouchida, M., Fukushima, K., Gunduz, E., Ito, S., Sakai, A., Nagai, N., Nishizaki, K., and Shimizu. K. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab. Invest., 83: 99-105, 2003.
39. Okada, S., Tsuda, H., Takarabe, T., Yoshikawa, H., Taketani, Y., and Hirohashi, S. Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types. Jpn. J. Cancer Res., 93: 798-806, 2002.
40. Cliby, W., Ritland, S., Hartmann, L., Dodson, M., Halling, K. C., Keeney, G., Podratz, K. C., and Jenkins, R. B. Human epithelial ovarian cancer allelotype. Cancer Res., 53: 2393-2398, 1993.
41. Han, H. S., Kim, H. S., Woo, D. K., Kim, W. H., and Kim, Y. I. Loss of heterozygosity in gastric neuroendocrine tumor. Anticancer Res., 20: 2849-2854, 2000.
42. Hu, N., Roth, M. J., Emmert-Buck, M. R., Tang, Z. Z., Polymeropolous, M., Wang, Q. H., Goldstein, A. M., Han, X. Y., Dawsey, S. M., Ding, T., Giffen, C., and Taylor, P. R. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer. Clin. Cancer Res., 5: 3476-3482, 1999.
43. Stanton, S. E., Shin, S. W., Johnson, B. E., and Meyerson, M. Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas. Genes Chromosomes Cancer, 27: 323-331, 2000.